Marshall Wace’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,509,769
Closed -$38.6M 3309
2025
Q4
$38.6M Buy
2,509,769
+473,766
+23% +$5.22M 0.04% 413
2025
Q3
$20.2M Buy
2,036,003
+221,069
+12% +$2.3M 0.02% 649
2025
Q2
$18M Buy
1,814,934
+939,076
+107% +$9.9M 0.02% 629
2025
Q1
$11.4M Buy
+875,858
New +$11.6M 0.01% 725
2024
Q3
Sell
-80,300
Closed -$902K 2601
2024
Q2
$902K Buy
+80,300
New +$935K ﹤0.01% 1732
2024
Q1
Sell
-164,207
Closed -$2.3M 2527
2023
Q4
$2.3M Buy
164,207
+76,684
+88% +$1.07M ﹤0.01% 1165
2023
Q3
$1.29M Buy
+87,523
New +$1.23M ﹤0.01% 1407
2022
Q4
Sell
-444,132
Closed -$4.64M 3039
2022
Q3
$4.64M Buy
+444,132
New +$5.79M 0.01% 1416
2022
Q2
Sell
-866,332
Closed -$9.39M 3514
2022
Q1
$9.39M Buy
866,332
+14,437
+2% +$175K 0.02% 922
2021
Q4
$12M Sell
851,895
-4,264,961
-83% -$70.2M 0.02% 740
2021
Q3
$98.3M Buy
+5,116,856
New +$68M 0.41% 29
2021
Q2
Sell
-346,586
Closed -$3.41M 2738
2021
Q1
$3.41M Buy
+346,586
New +$2.86M 0.02% 1044
2019
Q2
Sell
-16,449
Closed -$120K 1454
2019
Q1
$120K Buy
16,449
+11,387
+225% +$111K ﹤0.01% 1412
2018
Q4
$46K Sell
5,062
-73,524
-94% -$814K ﹤0.01% 1450
2018
Q3
$974K Buy
+78,586
New +$1.06M 0.01% 814
2016
Q2
Sell
-48,285
Closed -$929K 1024
2016
Q1
$929K Buy
+48,285
New +$976K 0.01% 733
2015
Q4
Sell
-9,727
Closed -$239K 1005
2015
Q3
$239K Sell
9,727
-42,650
-81% -$1.21M ﹤0.01% 838
2015
Q2
$1.23M Buy
+52,377
New +$1.14M 0.02% 563

Other funds holding DVAX

Marshall Wace's DVAX Position: Q1 2026 in Review

Marshall Wace sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 2,509,769 shares — an estimated $38.6M sold.

Marshall Wace first reported a position in DVAX in Q2 2015 and held it in 18 quarters. The position peaked at $98.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Marshall Wace reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 2,509,769 Dynavax Technologies shares in Q1 2026, an estimated $38.6M.
  • Marshall Wace first reported a position in Dynavax Technologies in Q2 2015 and held it in 18 quarters.
  • Marshall Wace's Dynavax Technologies position peaked at $98.3M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.